Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1998 Mar;132(3 Pt 1):527-30.
doi: 10.1016/s0022-3476(98)70034-4.

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy

C F Barlow  1 , C J Priebe, J B Mulliken, P D Barnes, D Mac Donald, J Folkman, R A Ezekowitz
Affiliations
Case Reports

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy

C F Barlow et al. J Pediatr. 1998 Mar.

Abstract

We report the development of spastic diplegia in infants during the course of interferon Alfa-2a (IFN) therapy for potentially life-endangering hemangiomas. Five infants who displayed diplegia were selected from a group of 26 infants treated with IFN. Diplegia persisted in three infants, and in the remaining two significant recovery occurred after IFN was discontinued. Magnetic resonance imaging showed no significant brain or spinal abnormalities except minor to moderate delayed myelination in two patients. Myelination was normal on subsequent radiographic examination in all five patients. We conclude that IFN can adversely affect the immature central nervous system and produce spastic diplegia, which is potentially reversible. We recommend careful clinical assessment of neurodevelopmental status during IFN therapy.

PubMed Disclaimer

Comment in

  • Spastic diplegia and interferon.
    Deb G, Jenkner A, Donfrancesco A. Deb G, et al. J Pediatr. 1999 Mar;134(3):382. doi: 10.1016/s0022-3476(99)70474-9. J Pediatr. 1999. PMID: 10064684 No abstract available.

Publication types